Get the Stockscreener App
4.96
2.27%
0.11
After Hours:
4.96
Sophia Genetics Sa stock is traded at $4.96, with a volume of 148.77K.
It is up +2.27% in the last 24 hours and up +7.59% over the past month.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
See More
Previous Close:
$4.85
Open:
$4.87
24h Volume:
148.77K
Relative Volume:
0.79
Market Cap:
$355.48M
Revenue:
$77.27M
Net Income/Loss:
$-79.00M
P/E Ratio:
-4.2415
EPS:
-1.1694
Net Cash Flow:
$-48.46M
1W Performance:
+1.22%
1M Performance:
+7.59%
6M Performance:
+17.26%
1Y Performance:
+71.63%
1-Day Range:
$4.73
$5.28
1-Week Range:
$4.60
$5.28
52-Week Range:
$2.58
$5.70
Sophia Genetics Sa Stock (SOPH) Company Profile
Name
Sophia Genetics Sa
Sector
Industry
Phone
-
Address
-
Compare SOPH vs VEEV, TEM, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
4.96 | 336.84M | 77.27M | -79.00M | -48.46M | -1.1694 |
VEEV
Veeva Systems Inc
|
159.09 | 24.73B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
49.53 | 7.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
46.04 | 8.71B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
81.36 | 6.59B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
22.43 | 4.12B | 1.10B | 112.09M | 283.19M | 0.6096 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-24 | Initiated | Craig Hallum | Buy |
| Aug-07-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-27-24 | Initiated | Guggenheim | Buy |
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| Jan-03-23 | Initiated | BTIG Research | Buy |
| Nov-23-22 | Initiated | Credit Suisse | Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-17-21 | Initiated | Cowen | Outperform |
| Aug-17-21 | Initiated | Credit Suisse | Outperform |
| Aug-17-21 | Initiated | JP Morgan | Overweight |
| Aug-17-21 | Initiated | Morgan Stanley | Overweight |
View All
Sophia Genetics Sa Stock (SOPH) Latest News
SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $13,552.00 in Stock - MarketBeat
Philippe Menu Sells 2,800 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) CEO Sells $13,552.00 in Stock - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) President Sells $13,484.24 in Stock - MarketBeat
Manuela Valente Sells 3,824 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $13,875.85 in Stock - MarketBeat
Wall Street Recap: Is SOPHiA GENETICS SA stock a hidden gem2026 Technical Patterns & Daily Growth Stock Investment Tips - baoquankhu1.vn
SOPHiA GENETICS (NASDAQ:SOPH) Insider Philippe Menu Sells 2,400 Shares - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Insider Well Daan Van Sells 2,705 Shares - MarketBeat
Insider 10b5-1 sales at SOPH (NASDAQ: SOPH) total 5,707 shares in Form 144 - Stock Titan
SOPHiA GENETICS (NASDAQ:SOPH) CFO George Cardoza Sells 2,520 Shares - MarketBeat
Manuela Valente Sells 2,376 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat
Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) CTO Sells 2,519 Shares of Stock - MarketBeat
SOPH SEC FilingsSophia Genetics Sa 10-K, 10-Q, 8-K Forms - Stock Titan
20,689 RSUs slated for sale; SOPH (NASDAQ: SOPH) Form 144 filing - Stock Titan
Proposed sale of 12,354 RSUs by executive | SOPH SEC FilingForm 144 - Stock Titan
18,556 SOPH Shares Registered for Sale; Insider 10b5-1 Trades (SOPH) - Stock Titan
SOPH (NASDAQ: SOPH) filing: Proposed resale of 6,335 RSU shares via Morgan Stanley - Stock Titan
SOPH insider 10b5-1 sales and RSU disclosures (Morgan Stanley Smith Barney LLC) - Stock Titan
SOPH (NASDAQ: SOPH) affiliate files Form 144; 8,797 RSU shares to be sold - Stock Titan
Insider sells large blocks under 10b5-1 plan | SOPH SEC FilingForm 144 - Stock Titan
Trading Recap: Is SOPHiA GENETICS SA backed by strong institutional buying2026 Breakouts & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Analyzing SOPHiA GENETICS (NASDAQ:SOPH) and iRhythm Technologies (NASDAQ:IRTC) - Defense World
How The SOPHiA GENETICS (SOPH) Narrative Is Shifting With Recalibrated Growth And Valuation Assumptions - Yahoo Finance
Aug PreEarnings: Can SOPHiA GENETICS SA stock double in the next year2026 Support & Resistance & Momentum Based Trading Ideas - baoquankhu1.vn
SOPHiA GENETICS (NASDAQ:SOPH) CEO Sells $21,398.22 in Stock - Defense World
SOPHiA GENETICS (NASDAQ:SOPH) CEO Jurgi Camblong Sells 4,486 Shares - MarketBeat
Form 144 SOPHiA GENETICS SA For: 19 March - Investing.com
Market Outlook: Is SOPHiA GENETICS SA a momentum stock2026 Earnings Surprises & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
ZHENYU XU sells shares under 10b5-1 plan (SOPH) - Stock Titan
Restricted Stock Units Sale Notice (SOPH) — 10b5-1 Transactions Listed - Stock Titan
1,183 RSUs Listed for Sale by SOPH Insider (NASDAQ: SOPH) - Stock Titan
Proposed sale of 774 Restricted Stock Units (SOPH) reported in Form 144 - Stock Titan
Morgan Stanley Smith Barney LLC (NASDAQ: SOPH) files Form 144 for 608 RSUs - Stock Titan
Manuela Valente 10b5-1 sales reported for SOPH (SOPH) - Stock Titan
[144] SOPHiA GENETICS SA SEC Filing - Stock Titan
Tomer Berkovitz Net Worth (2026) - GuruFocus
Jurgi Camblong (SOPH) reports multiple 10b5-1 sales across late 2025–2026 - Stock Titan
Trend Report: Can SOPHiA GENETICS SA continue delivering strong returns2026 Risk Factors & Stock Portfolio Risk Management - baoquankhu1.vn
Growth Recap: Why is SOPHiA GENETICS SA stock going downTake Profit & Accurate Entry/Exit Alerts - baoquankhu1.vn
SOPHiA GENETICS SA (NASDAQ:SOPH) Sees Significant Decrease in Short Interest - MarketBeat
[EFFECT] SOPHiA GENETICS SA SEC Filing - Stock Titan
Sophia Genetics Earnings Call: Growth Surges, Losses Linger - TipRanks
SOPHiA GENETICS (SOPH) Q4 Loss Deepens And Reinforces Bearish Profitability Concerns - Sahm
Will SOPHiA GENETICS SA stock go up in YEARQuarterly Trade Report & Technical Entry and Exit Alerts - baoquankhu1.vn
SOPHiA GENETICS Q4 Earnings Call Highlights - Defense World
Sophia Genetics SA (SOPH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
SOPHiA GENETICS S.A. (NASDAQ:SOPH) Q4 2025 Earnings Call Transcript - Insider Monkey
BTIG reiterates Sophia Genetics stock rating on customer growth - Investing.com South Africa
BTIG Maintains Buy on SOPHiA GENETICS S.A. (SOPH) March 03, 2026 - Meyka
SOPHiA GENETICS (NASDAQ: SOPH) registers 75,000 warrant shares for resale - Stock Titan
Sophia Genetics Sa Stock (SOPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.48%
1.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):